Bafilomycin-like metabolite from a novel micromonospora species

US7214705B2 · kind B2 · utility

Assignee

• Janssen Pharmaceutica NA · BE

Inventors

• Jacobus Alphonsus Josephus Van Dun · Kasterlee, BE
• Walter Boudewijn Leopold Wouters · Kapellen, BE
• Michel Janicot · Brussels, BE
• Ursula Maria Mocek · Bellevue, US
• Jodi A. Laakso · North Bend, US

Key dates

• Filing date: Jun 30, 2003
• Grant date: May 8, 2007
• Expiry date: Jun 30, 2023

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12R2001/29
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention provides a compound of formula (I) and pharmaceutically acceptable salts thereof. Processes for the isolating of this bafilomycin metabolite from a novel Micromonospora species, pharmaceutical compositions containing this metabolite and methods of treatment using said metabolite are also described